medalphabetМедицинский алфавитMedical alphabet2078-56312949-2807ООО «Альфмед»10.33667/2078-5631-2021-21-89-93medalphabet-2209Research ArticleЭНДОКРИНОЛОГИЯENDOCRINOLOGYРоль витамина D у больных с нарушениями ритма сердца (фибрилляцией предсердий). Персонализация питания (обзорная статья)Role of vitamin D in patients with cardiac arrhythmias (atrial fibrillation). Personalization of nutritionhttps://orcid.org/0000-0002-0548-3414БалашоваН. В.BalashovaN. V.

Балашова Наталья Валерьевна – кандидат биологических наук, доцент кафедры клинической лабораторной диагностики факультета усовершенствования врачей.

Москва.

SPIN: 2355-6837.

AuthorID: 832745.

Natalya V. Balashova - PhD Bio, assistant professor at Dept of Clinical Laboratory Diagnostics of the Faculty of Advanced Training of Doctors.

Moscow.

SPIN: 2355-6837.

AuthorID: 832745.

BalashovaN77@mail.ruГулиаЛ. Д.GuliaL. D.

Гулиа Леонид Деомидович - врач отделения хирургического лечения сложных нарушений ритма сердца и электрокардиостимуляции.

Москва.

eLIBRARY ID: 26229976

Leonid D. Gulia - physician at Dept of Surgical Treatment of Complex Heart Rhythm Disorders and Electrocardiostimulation.

Moscow.

eLIBRARY ID: 26229976.

doctor_gulia@mail.ruБенияР. М.BeniyaR. M.

Бения Роланд Мушниевич – кандидат медицинских наук, заведующий отделением хирургического лечения сложных нарушений ритма сердца и электрокардиостимуляции.

Москва.

eLibrary ID: 11744997

Roland M. Beniya - PhD Med, head of Dept of Surgical Treatment of Complex Heart Rhythm Disorders and Electrocardiostimulation.

Moscow.

eLIBRARY ID: 11744997.

doctorbenia@mail.ruhttps://orcid.org/0000-0002-4689-3591ОрловаС. В.OrlovaS. V.

Орлова Светлана Владимировна – доктор медицинских наук, профессор, заведующая кафедрой диетологии и клинической нутрициологии.

Москва.

Svetlana V. Orlova - DM Sci, professor, head of Dept of Dietetics and Clinical Nutritiology.

Moscow.

rudn_nutr@mail.ruhttps://orcid.org/0000-0003-3220-0333НикитинаЕ. А.NikitinaE. A.

Никитина Елена Александровна - кандидат медицинских наук, доцент кафедры диетологии и клинической нутрициологии.

Москва.

Elena A. Nikitina - PhD Med, assistant professor at Dept of Dietetics and Clinical Nutritiology.

Moscow.

nikitina-ea1@rudn.ruМосковский областной научно-исследовательский клинический институт имени М.Ф. ВладимирскогоРоссияMoscow Regional Research Clinical Institute n.a. M.F. VladimirskyRussian FederationРоссийский университет дружбы народовРоссияPeoples' Friendship University of RussiaRussian Federation202125092021021Диетология и нутрициология (1)8993Copyright © Балашова Н.В., Гулиа Л.Д., Бения Р.М., Орлова С.В., Никитина Е.А., 20212021Балашова Н.В., Гулиа Л.Д., Бения Р.М., Орлова С.В., Никитина Е.А.Balashova N.V., Gulia L.D., Beniya R.M., Orlova S.V., Nikitina E.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-alphabet.com/jour/article/view/2209

Несмотря на успехи в диагностике и лечении различного рода форм нарушений ритма сердца, фибрилляции предсердий (ФП) остается серьезной проблемой в клинике внутренних болезней, особенно остро стоящей в геронтологии. Предупреждение развития нарушений ритма сердца является важной медико-социальной задачей. Большую роль в профилактике сердечно-сосудистых заболеваний играет правильное питание. Вместе с тем дефицит витаминов и минералов, в том числе витамина D, может создавать патогенетическую основу для развития нарушений ритма. В экспериментальных и клинических исследованиях продемонстрировано влияние витамина D на механизмы, лежащие в основе формирования ФП. Скрининг на выявление дефицита витамина D у кардиологических пациентов должен стать рутинным. Коррекция дефицита витамина D должна проводиться персонифицированно. Необходимо проведение дальнейших клинических исследований для изучения конечных клинических точек (морбидности и летальности) при дополнительном приеме витамина D в аритмологии.

Despite advances in the diagnosis and treatment of various forms of cardiac arrhythmias, atrial fibrillation (AF) remains a serious problem in the internal medicine clinic, especially acute in gerontology. Prevention of the development of cardiac arrhythmias is an important medical and social task. Adequate nutrition plays an important role in the cardiovascular diseases prophylaxis. At the same time, a deficiency of vitamins and minerals, including vitamin D, can create a pathogenetic basis for the development of arrhythmias. Experimental and clinical studies have demonstrated the effect of vitamin D on the mechanisms underlying the formation of AF. Screening for vitamin D deficiency in cardiac patients should become routine. Correcting vitamin D deficiencies must be personalized. Further clinical trials are needed to investigate the clinical endpoints (morbidity and mortality) of vitamin D supplementation in arrhythmology.

нарушения ритма сердцафибрилляция предсердийвитамин Dконцентрация 25(OH)Dheart rhythm disordersatrial fibrillationvitamin D25(ОН)О levelReferencesHuang WL, Yang J, Yang J, Wang HB, Yang CJ, Yang Y. Vitamin D and new-onset atrial fibrillation: A meta-analysis of randomized controlled trials. Hellenic J Cardiol. 2018 Mar-Apr; 59 (2): 72-77.Huang WL, Yang J, Yang J, Wang HB, Yang CJ, Yang Y. Vitamin D and new-onset atrial fibrillation: A meta-analysis of randomized controlled trials. Hellenic J Cardiol. 2018 Mar-Apr; 59 (2): 72-77.Nattel S. Molecular and Cellular Mechanisms of Atrial Fibrosis in Atrial Fibrillation. JACC Clin Electrophysiol. 2017 May; 3 (5): 425-435. DOI: 10.1016/j.jacep.2017.03.002. Epub 2017 May 15. PMID: 29759598.Nattel S. Molecular and Cellular Mechanisms of Atrial Fibrosis in Atrial Fibrillation. JACC Clin Electrophysiol. 2017 May; 3 (5): 425-435. DOI: 10.1016/j.jacep.2017.03.002. Epub 2017 May 15. PMID: 29759598.Derangeon M, Montnach J, Cerpa CO, Jagu B, Patin J, Toumaniantz G, Girardeau A, Huang CLH, Colledge WH, Grace AA, Bard I, Charpentier F. Transforming growth factor в receptor inhibition prevents ventricular fibrosis in a mouse model of progressive cardiac conduction disease. Cardiovasc Res. 2017 Apr 1; 113 (5): 464-474. DOI: 10.1093/cvr/cvx026. PMID: 28339646.Derangeon M, Montnach J, Cerpa CO, Jagu B, Patin J, Toumaniantz G, Girardeau A, Huang CLH, Colledge WH, Grace AA, Bard I, Charpentier F. Transforming growth factor в receptor inhibition prevents ventricular fibrosis in a mouse model of progressive cardiac conduction disease. Cardiovasc Res. 2017 Apr 1; 113 (5): 464-474. DOI: 10.1093/cvr/cvx026. PMID: 28339646.Zhang JC, Chen JQ, Xu CX, Chen L, Lin YZ, Wu GS. [Effect of hepatocyte growth factor and transforming growth factor-e(1) on atrial fibroblasts fibrosis]. Zhonghua Xin Xue Guan Bing Za Zhi. 2012 Oct; 40 (10): 834-9. Chinese. PMID: 23302670.Zhang JC, Chen JQ, Xu CX, Chen L, Lin YZ, Wu GS. [Effect of hepatocyte growth factor and transforming growth factor-e(1) on atrial fibroblasts fibrosis]. Zhonghua Xin Xue Guan Bing Za Zhi. 2012 Oct; 40 (10): 834-9. Chinese. PMID: 23302670.Li Y, Jian Z, Yang ZY, Chen L, Wang XF, Ma RY, Xiao YB. Increased expression of connective tissue growth factor and transforming growth factor-beta-1 in atrial myocardium of patients with chronic atrial fibrillation. Cardiology. 2013; 124 (4): 233-40. DOI: 10.1159/000347126. Epub 2013 Apr 6. PMID: 23571482.Li Y, Jian Z, Yang ZY, Chen L, Wang XF, Ma RY, Xiao YB. Increased expression of connective tissue growth factor and transforming growth factor-beta-1 in atrial myocardium of patients with chronic atrial fibrillation. Cardiology. 2013; 124 (4): 233-40. DOI: 10.1159/000347126. Epub 2013 Apr 6. PMID: 23571482.Shen H, Wang J, Min J, Xi W, Gao Y, Yin L, Yu Y, Liu K, Xiao J, Zhang YF, Wang ZN. Activation of TGF-ei/a-SMA/Col I Profibrotic Pathway in Fibroblasts by Galectin-3 Contributes to Atrial Fibrosis in Experimental Models and Patients. Cell Physiol Biochem. 2018; 47 (2): 851-863. DOI: 10.1159/000490077. Epub 2018 May 22. PMID: 29807358.Shen H, Wang J, Min J, Xi W, Gao Y, Yin L, Yu Y, Liu K, Xiao J, Zhang YF, Wang ZN. Activation of TGF-ei/a-SMA/Col I Profibrotic Pathway in Fibroblasts by Galectin-3 Contributes to Atrial Fibrosis in Experimental Models and Patients. Cell Physiol Biochem. 2018; 47 (2): 851-863. DOI: 10.1159/000490077. Epub 2018 May 22. PMID: 29807358.Yeh YH, Kuo CT, Chan TH, Chang GJ, Qi XY, Tsai F, Nattel S, Chen WJ. Transforming growth factor-в and oxidative stress mediate tachycardia-induced cellular remodelling in cultured atrial-derived myocytes. Cardiovasc Res. 2011 Jul 1; 91 (1): 62-70. DOI: 10.1093/cvr/cvr041. Epub 2011 Feb 2. PMID: 21289011.Yeh YH, Kuo CT, Chan TH, Chang GJ, Qi XY, Tsai F, Nattel S, Chen WJ. Transforming growth factor-в and oxidative stress mediate tachycardia-induced cellular remodelling in cultured atrial-derived myocytes. Cardiovasc Res. 2011 Jul 1; 91 (1): 62-70. DOI: 10.1093/cvr/cvr041. Epub 2011 Feb 2. PMID: 21289011.Chang SH, Yeh YH, Lee JL, Hsu YJ, Kuo CT, Chen WJ. Transforming growth factor-fi-mediated CD 44/STAT3 signaling contributes to the development of atrial fibrosis and fibrillation. Basic Res Cardiol. 2017 Sep 4; 112 (5): 58. DOI: 10.1007/s00395-017-0647-9. PMID: 28871329.Chang SH, Yeh YH, Lee JL, Hsu YJ, Kuo CT, Chen WJ. Transforming growth factor-fi-mediated CD 44/STAT3 signaling contributes to the development of atrial fibrosis and fibrillation. Basic Res Cardiol. 2017 Sep 4; 112 (5): 58. DOI: 10.1007/s00395-017-0647-9. PMID: 28871329.Platonov PG, Mitrofanova LB, Orshanskaya V, Ho SY. Structural abnormalities in atrial walls are associated with presence and persistency of atrial fibrillation but not with age. J Am Coll Cardiol. 2011 Nov 15; 58 (21): 2225-32. DOI: 10.1016/j.jacc.2011.05.061. PMID: 22078429.Platonov PG, Mitrofanova LB, Orshanskaya V, Ho SY. Structural abnormalities in atrial walls are associated with presence and persistency of atrial fibrillation but not with age. J Am Coll Cardiol. 2011 Nov 15; 58 (21): 2225-32. DOI: 10.1016/j.jacc.2011.05.061. PMID: 22078429.Hu YF, Chen YJ, Lin YJ, Chen SA. Inflammation and the pathogenesis of atrial fibrillation. Nat Rev Cardiol. 2015 Apr; 12 (4): 230-43. DOI: 10.1038/nrcardio.2015.2. Epub 2015 Jan 27. PMID: 25622848.Hu YF, Chen YJ, Lin YJ, Chen SA. Inflammation and the pathogenesis of atrial fibrillation. Nat Rev Cardiol. 2015 Apr; 12 (4): 230-43. DOI: 10.1038/nrcardio.2015.2. Epub 2015 Jan 27. PMID: 25622848.Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, Block D, Zhang J, Soden R, Hayakawa M, Kreiman G, Cooke MP, Walker JR, Hogenesch JB. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci USA. 2004 Apr 20; 101 (16): 6062-7. DOI: 10.1073/pnas.0400782101. Epub 2004 Apr 9. PMID: 15075390; PMCID: PMC 395923.Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, Block D, Zhang J, Soden R, Hayakawa M, Kreiman G, Cooke MP, Walker JR, Hogenesch JB. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci USA. 2004 Apr 20; 101 (16): 6062-7. DOI: 10.1073/pnas.0400782101. Epub 2004 Apr 9. PMID: 15075390; PMCID: PMC 395923.Клинические рекомендации. Дефицит витамина D у взрослых, 2016 г. https://www.rae-org.ru/system/files/documents/pdf/kr342_deficit_vitamina_d_u_vzroslyh.pdfClinical guidelines. Vitamin D deficiency in adults. Year of approval: 2016. https://www.rae-org.ru/system/files/documents/pdf/kr342_deficit_vitamina_d_u_vzroslyh.pdfМетодические рекомендации МР2.3.1.2432-08 «Нормы физиологических потребностей в энергии и пищевых веществах для различных групп населения Российской Федерации». 2008 г.Methodical recommendations MR 2.3.1.2432-08 «Norms of physiological needs for energy and nutrients for various groups of the population of the Russian Federation». Year of approval: 2008.Quack Lotscher KC, l’Allemand D, Bischoff-Ferrari HA, et al. (2012) Vitamin D Deficiency: Evidence, Safety, and Recommendations for the Swiss Population. Switzerland: Federal Office of Public Health.Quack Lotscher KC, l’Allemand D, Bischoff-Ferrari HA, et al. (2012) Vitamin D Deficiency: Evidence, Safety, and Recommendations for the Swiss Population. Switzerland: Federal Office of Public Health.Тутельян В. А. Химический состав и калорийность российских продуктов питания. Справочник. М.: ДеЛи плюс, 2012. 284 с.Tutelyan V. A. Chemical composition and caloric content of Russian food products. Directory. M .: DeLi plus, 2012. 284 p.Химический состав пищевых продуктов. Кн. 2: Справочные таблицы содержания аминокислот, жирных кислот, витаминов, макро- и микроэлементов, органических кислот и углеводов. Под ред. проф., д-ра техн. наук И. М. Скурихина и проф., д-ра мед. наук М. Н. Волгарева. 2-е изд., перераб. и доп. М.: Агропромиздат, 1987. 360 с.Chemical composition of food products. Book. 2: Reference tables of the content of amino acids, fatty acids, vitamins, macro- and microelements, organic acids and carbohydrates. Ed. prof., Dr. tech. sciences IM Skurikhin and prof., Dr. med. M. N. Volgareva. 2nd ed., Rev. and add. M.: Agropromizdat, 1987. 360 p.Webb AR, Kline L, Holick MF. Influence of season and latitude on the cutaneous synthesis of vitamin D 3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D 3 synthesis in human skin. J Clin Endocrinol Metab. 1988 Aug; 67 (2): 373-8. DOI: 10.1210/jcem-67-2-373. PMID: 2839537.Webb AR, Kline L, Holick MF. Influence of season and latitude on the cutaneous synthesis of vitamin D 3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D 3 synthesis in human skin. J Clin Endocrinol Metab. 1988 Aug; 67 (2): 373-8. DOI: 10.1210/jcem-67-2-373. PMID: 2839537.Pilz S, Marz W, Cashman KD, Kiely ME, Whiting SJ, Holick MF, Grant WB, Pludowski P, Hiligsmann M, Trummer C, Schwetz V, Lerchbaum E, Pandis M, Tomaschitz A, Grubler MR, Gaksch M, Verheyen N, Hollis BW, Rejnmark L, Karras SN, Hahn A, Bischoff-Ferrari HA, Reichrath J, Jorde R, Elmadfa I, Vieth R, Scragg R, Calvo MS, van Schoor NM, Bouillon R, Lips P, Itkonen ST, Martineau AR, Lamberg-Allardt C, Zittermann A. Rationale and Plan for Vitamin D Food Fortification: A Review and Guidance Paper. Front Endocrinol (Lausanne). 2018 Jul 17; 9: 373. DOI: 10.3389/fendo.2018.00373. PMID: 30065699; PMCID: PMC 6056629.Pilz S, Marz W, Cashman KD, Kiely ME, Whiting SJ, Holick MF, Grant WB, Pludowski P, Hiligsmann M, Trummer C, Schwetz V, Lerchbaum E, Pandis M, Tomaschitz A, Grubler MR, Gaksch M, Verheyen N, Hollis BW, Rejnmark L, Karras SN, Hahn A, Bischoff-Ferrari HA, Reichrath J, Jorde R, Elmadfa I, Vieth R, Scragg R, Calvo MS, van Schoor NM, Bouillon R, Lips P, Itkonen ST, Martineau AR, Lamberg-Allardt C, Zittermann A. Rationale and Plan for Vitamin D Food Fortification: A Review and Guidance Paper. Front Endocrinol (Lausanne). 2018 Jul 17; 9: 373. DOI: 10.3389/fendo.2018.00373. PMID: 30065699; PMCID: PMC 6056629.Grossmann RE, Tangpricha V. Evaluation of vehicle substances on vitamin D bioavailability: a systematic review. Mol Nutr Food Res. 2010 Aug; 54 (8): 1055-61. DOI: 10.1002/mnfr.200900578. PMID: 20425758; PMCID: PMC 3033429.Grossmann RE, Tangpricha V. Evaluation of vehicle substances on vitamin D bioavailability: a systematic review. Mol Nutr Food Res. 2010 Aug; 54 (8): 1055-61. DOI: 10.1002/mnfr.200900578. PMID: 20425758; PMCID: PMC 3033429.Simoliunas E, Rinkunaite I, Bukelskiene Z, Bukelskiene V. Bioavailability of Different Vitamin D Oral Supplements in Laboratory Animal Model. Medicina (Kaunas). 2019 Jun 10; 55 (6): 265. DOI: 10.3390/medicina55060265. PMID: 31185696; PMCID: PMC 6631968.Simoliunas E, Rinkunaite I, Bukelskiene Z, Bukelskiene V. Bioavailability of Different Vitamin D Oral Supplements in Laboratory Animal Model. Medicina (Kaunas). 2019 Jun 10; 55 (6): 265. DOI: 10.3390/medicina55060265. PMID: 31185696; PMCID: PMC 6631968.Quesada-Gomez JM, Bouillon R. Is calcifediol better than cholecalciferol for vitamin D supplementation? Osteoporos Int. 2018 Aug; 29 (8): 1697-1711. DOI: 10.1007/s00198-018-4520-y. Epub 2018 Apr 30. PMID: 29713796.Quesada-Gomez JM, Bouillon R. Is calcifediol better than cholecalciferol for vitamin D supplementation? Osteoporos Int. 2018 Aug; 29 (8): 1697-1711. DOI: 10.1007/s00198-018-4520-y. Epub 2018 Apr 30. PMID: 29713796.Graeff-Armas LA, Bendik I, Kunz I, Schoop R, Hull S, Beck M. Supplemental 25-Hydroxycholecal-ciferol Is More Effective than Cholecalciferol in Raising Serum 25-Hydroxyvitamin D Concentrations in Older Adults. J Nutr. 2020 Jan 1; 150 (1): 73-81. DOI: 10.1093/jn/nxz209. PMID: 31518424.Graeff-Armas LA, Bendik I, Kunz I, Schoop R, Hull S, Beck M. Supplemental 25-Hydroxycholecal-ciferol Is More Effective than Cholecalciferol in Raising Serum 25-Hydroxyvitamin D Concentrations in Older Adults. J Nutr. 2020 Jan 1; 150 (1): 73-81. DOI: 10.1093/jn/nxz209. PMID: 31518424.Vaes AMM, Tieland M, de Regt MF, Wittwer J, van Loon LJC, de Groot LCPGM. Dose-response effects of supplementation with calcifediol on serum 25-hydroxyvitamin D status and its metabolites: A randomized controlled trial in older adults. Clin Nutr. 2018 Jun; 37 (3): 808-814. DOI: 10.1016/j.clnu.2017.03.029. Epub 2017 Mar 31. PMID: 28433267.Vaes AMM, Tieland M, de Regt MF, Wittwer J, van Loon LJC, de Groot LCPGM. Dose-response effects of supplementation with calcifediol on serum 25-hydroxyvitamin D status and its metabolites: A randomized controlled trial in older adults. Clin Nutr. 2018 Jun; 37 (3): 808-814. DOI: 10.1016/j.clnu.2017.03.029. Epub 2017 Mar 31. PMID: 28433267.Carvalho LS, Sposito AC. Vitamin D for the prevention of cardiovascular disease: Are we ready for that? Atherosclerosis. 2015 Aug; 241 (2): 729-40. DOI: 10.1016/j.athero-sclerosis.2015.06.034. Epub 2015 Jun 21. PMID: 26135478 Review.Carvalho LS, Sposito AC. Vitamin D for the prevention of cardiovascular disease: Are we ready for that? Atherosclerosis. 2015 Aug; 241 (2): 729-40. DOI: 10.1016/j.athero-sclerosis.2015.06.034. Epub 2015 Jun 21. PMID: 26135478 Review.Bagrul D, Atik F. Association of vitamin D deficiency with ventricular repolarization abnormalities. Kardiol Pol. 2019 Aug 23; 77 (9): 853-858. DOI: 10.33963/KP.14888. Epub 2019 Jul 3. PMID: 31289258.Bagrul D, Atik F. Association of vitamin D deficiency with ventricular repolarization abnormalities. Kardiol Pol. 2019 Aug 23; 77 (9): 853-858. DOI: 10.33963/KP.14888. Epub 2019 Jul 3. PMID: 31289258.Trevisan C, Piovesan F, Lucato P, Zanforlini BM, De Rui M, Maggi S, Noale M, Corti MC, Perissinotto E, Manzato E, Sergi G. Parathormone, vitamin D and the risk of atrial fibrillation in older adults: A prospective study. Nutr Metab Cardiovasc Dis. 2019 Sep; 29 (9): 939-945. DOI: 10.1016/j.numecd.2019.05.064. Epub 2019 May 29. PMID: 31303477.Trevisan C, Piovesan F, Lucato P, Zanforlini BM, De Rui M, Maggi S, Noale M, Corti MC, Perissinotto E, Manzato E, Sergi G. Parathormone, vitamin D and the risk of atrial fibrillation in older adults: A prospective study. Nutr Metab Cardiovasc Dis. 2019 Sep; 29 (9): 939-945. DOI: 10.1016/j.numecd.2019.05.064. Epub 2019 May 29. PMID: 31303477.Thompson J, Nitiahpapand R, Bhatti P, Kourliouros A. Vitamin D deficiency and atrial fibrillation. Int J Cardiol. 2015 Apr 1; 184: 159-162. DOI: 10.1016/j.ijcard.2015.02.012. Epub 2015 Feb 10. PMID: 25705008.Thompson J, Nitiahpapand R, Bhatti P, Kourliouros A. Vitamin D deficiency and atrial fibrillation. Int J Cardiol. 2015 Apr 1; 184: 159-162. DOI: 10.1016/j.ijcard.2015.02.012. Epub 2015 Feb 10. PMID: 25705008.Cerit L. Bermuda triangle; heart failure, atrial fibrillation, and vitamin D deficiency. J Cardiovasc Med (Hagerstown). 2017 Feb; 18 (2): 121. DOI: 10.2459/JCM.0000000000000407. PMID: 28027213.Cerit L. Bermuda triangle; heart failure, atrial fibrillation, and vitamin D deficiency. J Cardiovasc Med (Hagerstown). 2017 Feb; 18 (2): 121. DOI: 10.2459/JCM.0000000000000407. PMID: 28027213.Ozsin KK, Sanri US, Tokta? F, Kahraman N, Yavuz §. Effect of Plasma Level of Vitamin D on Postoperative Atrial Fibrillation in Patients Undergoing Isolated Coronary Artery Bypass Grafting. Braz J Cardiovasc Surg. 2018 May-Jun; 33 (3): 217-223. DOI: 10.21470/16789741-2017-0214. PMID: 30043913; PMCID: PMC 6089122.Ozsin KK, Sanri US, Tokta? F, Kahraman N, Yavuz §. Effect of Plasma Level of Vitamin D on Postoperative Atrial Fibrillation in Patients Undergoing Isolated Coronary Artery Bypass Grafting. Braz J Cardiovasc Surg. 2018 May-Jun; 33 (3): 217-223. DOI: 10.21470/16789741-2017-0214. PMID: 30043913; PMCID: PMC 6089122.Cerit L. Vitamin D as a Modifiable Risk Factor for Incident Heart Failure in Atrial Fibrillation. JACC Heart Fail. 2018 Jan; 6 (1): 85-86. DOI: 10.1016/j.jchf.2017.08.007. PMID: 29284584.Cerit L. Vitamin D as a Modifiable Risk Factor for Incident Heart Failure in Atrial Fibrillation. JACC Heart Fail. 2018 Jan; 6 (1): 85-86. DOI: 10.1016/j.jchf.2017.08.007. PMID: 29284584.Bie L. The Status and Research Progress on Vitamin D Deficiency and Atrial Fibrillation. Braz J Cardiovasc Surg. 2019 Dec 1; 34 (5): 605-609. DOI: 10.21470/1678-9741-2018-0322. PMID: 31719011; PMCID: PMC 6852461.Bie L. The Status and Research Progress on Vitamin D Deficiency and Atrial Fibrillation. Braz J Cardiovasc Surg. 2019 Dec 1; 34 (5): 605-609. DOI: 10.21470/1678-9741-2018-0322. PMID: 31719011; PMCID: PMC 6852461.Turin A, Bax JJ, Doukas D, Joyce C, Lopez JJ, Mathew V, Pontone G, Shah F, Singh S, Wilber DJ, Rabbat MG. Interactions Among Vitamin D, Atrial Fibrillation, and the Renin-Angiotensin-Aldosterone System. Am J Cardiol. 2018 Sep 1; 122 (5): 780-784. DOI: 10.1016/j.amjcard.2018.05.013. Epub 2018 Jun 2. PMID: 30057228.Turin A, Bax JJ, Doukas D, Joyce C, Lopez JJ, Mathew V, Pontone G, Shah F, Singh S, Wilber DJ, Rabbat MG. Interactions Among Vitamin D, Atrial Fibrillation, and the Renin-Angiotensin-Aldosterone System. Am J Cardiol. 2018 Sep 1; 122 (5): 780-784. DOI: 10.1016/j.amjcard.2018.05.013. Epub 2018 Jun 2. PMID: 30057228.Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002 Jul; 110 (2): 229-38. DOI: 10.1172/JCI15219. PMID: 12122115; PMCID: PMC 151055.Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002 Jul; 110 (2): 229-38. DOI: 10.1172/JCI15219. PMID: 12122115; PMCID: PMC 151055.Muller DN, Kleinewietfeld M, Kvakan H. Vitamin D review. J Renin Angiotensin Aldosterone Syst. 2011 Jun; 12 (2): 125-8. DOI: 10.1177/1470320311410924. PMID: 21628362.Muller DN, Kleinewietfeld M, Kvakan H. Vitamin D review. J Renin Angiotensin Aldosterone Syst. 2011 Jun; 12 (2): 125-8. DOI: 10.1177/1470320311410924. PMID: 21628362.Москалёв А. В., Рудой А. С., Апчел А. В., Зуева В. О., Казымова О. Э. Особенности биологии трансформирующего ростового фактора в и иммунопатология. Вестн. Росс. военно-медицинской акад. 2016; 2 (54): 206-216.Moskalev A. V., Rudoy A. S., Apchel A. V., Zueva V. O., Kazymova O. E. Features of the biology of transforming growth factor в and immunopathology. Vestn. Ross. military medical acad. 2016; 2 (54): 206-216.Legarth C, Grimm D, Kruger M, Infanger M, Wehland M. Potential Beneficial Effects of Vitamin D in Coronary Artery Disease. Nutrients. 2019 Dec 30; 12 (1): 99. DOI: 10.3390/nu12010099. PMID: 31905893; PMCID: PMC 7019525.Legarth C, Grimm D, Kruger M, Infanger M, Wehland M. Potential Beneficial Effects of Vitamin D in Coronary Artery Disease. Nutrients. 2019 Dec 30; 12 (1): 99. DOI: 10.3390/nu12010099. PMID: 31905893; PMCID: PMC 7019525.Zhang Z, Yang Y, Ng CY, Wang D, Wang J, Li G, Liu T. Meta-analysis of Vitamin D deficiency and risk of atrial fibrillation. Clin Cardiol. 2016; 39: 537-43.Zhang Z, Yang Y, Ng CY, Wang D, Wang J, Li G, Liu T. Meta-analysis of Vitamin D deficiency and risk of atrial fibrillation. Clin Cardiol. 2016; 39: 537-43.Belen E, Aykan AC, Kalaycioglu E, Sungur MA, Sungur A, Cetin M. Low-Level Vitamin D Is Associated with Atrial Fibrillation in Patients with Chronic Heart Failure. Adv Clin Exp Med. 2016 Jan-Feb; 25 (1): 51-7. DOI: 10.17219/acem/34690. PMID: 26935498.Belen E, Aykan AC, Kalaycioglu E, Sungur MA, Sungur A, Cetin M. Low-Level Vitamin D Is Associated with Atrial Fibrillation in Patients with Chronic Heart Failure. Adv Clin Exp Med. 2016 Jan-Feb; 25 (1): 51-7. DOI: 10.17219/acem/34690. PMID: 26935498.Chen WR, Liu ZY, Shi Y, Yin DW, Wang H, Sha Y, Chen YD. Relation of low vitamin D to nonvalvular persistent atrial fibrillation in Chinese patients. Ann Noninvasive Electro-cardiol. 2014 Mar; 19 (2): 166-73. DOI: 10.1111/anec.12105. Epub 2013 Nov 8. PMID: 24206389; PMCID: PMC 6932220.Chen WR, Liu ZY, Shi Y, Yin DW, Wang H, Sha Y, Chen YD. Relation of low vitamin D to nonvalvular persistent atrial fibrillation in Chinese patients. Ann Noninvasive Electro-cardiol. 2014 Mar; 19 (2): 166-73. DOI: 10.1111/anec.12105. Epub 2013 Nov 8. PMID: 24206389; PMCID: PMC 6932220.Alonso A, Misialek JR, Michos ED, Eckfeldt J, Selvin E, Soliman EZ, Chen LY, Gross MD, Lutsey PL. Serum 25-hydroxyvitamin D and the incidence of atrial fibrillation: the atherosclerosis risk in communities (ARIC) study. Europace. 2016; 18: 1143-9.Alonso A, Misialek JR, Michos ED, Eckfeldt J, Selvin E, Soliman EZ, Chen LY, Gross MD, Lutsey PL. Serum 25-hydroxyvitamin D and the incidence of atrial fibrillation: the atherosclerosis risk in communities (ARIC) study. Europace. 2016; 18: 1143-9.Liu X, Wang W, Tan Z, Zhu X, Liu M, Wan R, Hong K. The relationship between vitamin D and risk of atrial fibrillation: a dose-response analysis of observational studies. Nutr J. 2019 Nov 14; 18 (1): 73. DOI: 10.1186/s12937-019-0485-8. PMID: 31727055; PMCID: PMC 6857145.Liu X, Wang W, Tan Z, Zhu X, Liu M, Wan R, Hong K. The relationship between vitamin D and risk of atrial fibrillation: a dose-response analysis of observational studies. Nutr J. 2019 Nov 14; 18 (1): 73. DOI: 10.1186/s12937-019-0485-8. PMID: 31727055; PMCID: PMC 6857145.Qakir OM. Low vitamin D levels predict left atrial thrombus in nonvalvular atrial fibrillation. Nutr Metab Cardiovasc Dis. 2020 Jun 25; 30 (7): 1152-1160. DOI: 10.1016/j.numecd.2020.03.023. Epub 2020 Apr 9. PMID: 32456946.Qakir OM. Low vitamin D levels predict left atrial thrombus in nonvalvular atrial fibrillation. Nutr Metab Cardiovasc Dis. 2020 Jun 25; 30 (7): 1152-1160. DOI: 10.1016/j.numecd.2020.03.023. Epub 2020 Apr 9. PMID: 32456946.Scragg R, Stewart AW, Waayer D, Lawes CMM, Toop L, Sluyter J, Murphy J, Khaw KT, Camargo CA Jr. Effect of Monthly High-Dose Vitamin D Supplementation on Cardiovascular Disease in the Vitamin D Assessment Study: A Randomized Clinical Trial. JAMA Cardiol. 2017 Jun 1; 2 (6): 608-616. DOI: 10.1001/jamacardio.2017.0175. PMID: 28384800; PMCID: PMC 5815022.Scragg R, Stewart AW, Waayer D, Lawes CMM, Toop L, Sluyter J, Murphy J, Khaw KT, Camargo CA Jr. Effect of Monthly High-Dose Vitamin D Supplementation on Cardiovascular Disease in the Vitamin D Assessment Study: A Randomized Clinical Trial. JAMA Cardiol. 2017 Jun 1; 2 (6): 608-616. DOI: 10.1001/jamacardio.2017.0175. PMID: 28384800; PMCID: PMC 5815022.Albert CM, Cook NR, Pester J, Moorthy MV, Ridge C, Danik JS, Gencer B, Siddiqi HK, Ng C, Gibson H, Mora S, Buring JE, Manson JE. Effect of Marine Omega-3 Fatty Acid and Vitamin D Supplementation on Incident Atrial Fibrillation: A Randomized Clinical Trial. JAMA. 2021 Mar 16; 325 (11): 1061-1073. DOI: 10.1001/jama.2021.1489. PMID: 33724323; PMCID: PMC 7967086.Albert CM, Cook NR, Pester J, Moorthy MV, Ridge C, Danik JS, Gencer B, Siddiqi HK, Ng C, Gibson H, Mora S, Buring JE, Manson JE. Effect of Marine Omega-3 Fatty Acid and Vitamin D Supplementation on Incident Atrial Fibrillation: A Randomized Clinical Trial. JAMA. 2021 Mar 16; 325 (11): 1061-1073. DOI: 10.1001/jama.2021.1489. PMID: 33724323; PMCID: PMC 7967086.Kara H, Yasim A. Effects of high-dose vitamin D supplementation on the occurrence of post-operative atrial fibrillation after coronary artery bypass grafting: randomized controlled trial. Gen Thorac Cardiovasc Surg. 2020 May; 68 (5): 477-484. DOI: 10.1007/s11748-019-01209-0. Epub 2019 Sep 26. PMID: 31559589.Kara H, Yasim A. Effects of high-dose vitamin D supplementation on the occurrence of post-operative atrial fibrillation after coronary artery bypass grafting: randomized controlled trial. Gen Thorac Cardiovasc Surg. 2020 May; 68 (5): 477-484. DOI: 10.1007/s11748-019-01209-0. Epub 2019 Sep 26. PMID: 31559589.Cerit L, Ozcem B, Cerit Z, Duygu H. Preventive Effect of Preoperative Vitamin D Supplementation on Postoperative Atrial Fibrillation. Braz J Cardiovasc Surg. 2018 Jul-Aug; 33 (4): 347-352. DOI: 10.21470/1678-9741-2018-0014. PMID: 30184031; PMCID: PMC 6122752.Cerit L, Ozcem B, Cerit Z, Duygu H. Preventive Effect of Preoperative Vitamin D Supplementation on Postoperative Atrial Fibrillation. Braz J Cardiovasc Surg. 2018 Jul-Aug; 33 (4): 347-352. DOI: 10.21470/1678-9741-2018-0014. PMID: 30184031; PMCID: PMC 6122752.

The authors declare that there are no conflicts of interest present.